Estimation of Intangible Costs for Factors Associated with Oral Antiviral Drugs for COVID-19 Treatment: A Conjoint Analysis in Japan.

Naoki Hosogaya Takahiro Takazono Kenji Kurazono Shinzo HiroiKosuke IwasakiTomomi TakeshimaChise HaHiroshi Mukae

Published in: Advances in therapy (2023)

Intangible costs for factors associated with oral antiviral drugs among the Japanese population were estimated. The results may change as the number of people with a history of COVID-19 infection increases and significant progress is made regarding treatments.

Keyphrases

coronavirus disease
sars cov
combination therapy
respiratory syndrome coronavirus
data analysis